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Abstract
Background: Otitis media (OM), one of the most common pediatric infectious diseases, causes inner ear
inflammation resulting in vertigo and sensorineural hearing loss. Previously, we showed that spiral ligament
fibrocytes (SLFs) recognize OM pathogens and up-regulate chemokines. Here, we aim to determine a key molecule
derived from SLFs, contributing to OM-induced inner ear inflammation.
Methods: Live NTHI was injected into the murine middle ear through the tympanic membrane, and histological
analysis was performed after harvesting the temporal bones. Migration assays were conducted using the
conditioned medium of NTHI-exposed SLFs with and without inhibition of MCP-1/CCL2 and CCR2. qRT-PCR
analysis was performed to demonstrate a compensatory up-regulation of alternative genes induced by the
targeting of MCP-1/CCL2 or CCR2.
Results: Transtympanic inoculation of live NTHI developed serous and purulent labyrinthitis after clearance of OM.
THP-1 cells actively migrated and invaded the extracellular matrix in response to the conditioned medium of NTHI-
exposed SLFs. This migratory activity was markedly inhibited by the viral CC chemokine inhibitor and the
deficiency of MCP-1/CCL2, indicating that MCP-1/CCL2 is a main attractant of THP-1 cells among the SLF-derived
molecules. We further demonstrated that CCR2 deficiency inhibits migration of monocyte-like cells in response to
NTHI-induced SLF-derived molecules. Immunolabeling showed an increase in MCP-1/CCL2 expression in the
cochlear lateral wall of the NTHI-inoculated group. Contrary to the in vitro data, deficiency of MCP-1/CCL2 or CCR2
did not inhibit OM-induced inner ear inflammation in vivo. We demonstrated that targeting MCP-1/CCL2 enhances
NTHI-induced up-regulation of MCP-2/CCL8 in SLFs and up-regulates the basal expression of CCR2 in the
splenocytes. We also found that targeting CCR2 enhances NTHI-induced up-regulation of MCP-1/CCL2 in SLFs.
Conclusions: Taken together, we suggest that NTHI-induced SLF-derived MCP-1/CCL2 is a key molecule
contributing to inner ear inflammation through CCR2-mediated recruitment of monocytes. However, deficiency of
MCP-1/CCL2 or CCR2 alone was limited to inhibit OM-induced inner ear inflammation due to compensation of
alternative genes.
Background
Otitis media (OM) is one of the most common infec-
tious diseases in children and it is estimated to cost
more than $5 billion annually in the U.S. for the man-
agement of OM [1,2]. OM is not a life-threatening dis-
ease, but causes inner ear complications such as
sensorineural hearing loss (SNHL) [3] and vertigo [4].
OM-induced inner ear complications of children are
clinically important since even a mild hearing loss can
interfere with a child’s language development, [5] and
balance dysfunction is associated with delays in achieve-
ment of motor milestones [6].
The incidence of OM-induced SNHL may be underes-
timated since OM results in hearing loss in ultrahigh
frequencies as well as transient hearing threshold shifts,
which cannot be easily detected with a conventional
hearing test [7,8]. OM-induced SNHL is believed to be
caused by immune-mediated damage due to inner ear
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any medium, provided the original work is properly cited.inflammation, which is initiated by the entry of bacterial
molecules of OM pathogens into the inner ear through
the round window membrane [9]. Animal studies of
pneumococcal OM demonstrate cochlear damage such
as hair cell loss [10] and pathologic changes in the
cochlear lateral wall [11,12].
Since pneumococcal conjugate vaccination has caused a
shift in the predominant OM pathogens, nontypeable
H. influenzae (NTHI) is becoming the most commonly-
isolated organism of OM [13]. NTHI is a small Gram-
negative bacterium, existing as a commensal organism in
the human nasopharynx. The clinical course of NTHI-
induced OM is less severe and is more chronically
associated with middle ear effusion compared to that of
pneumococcal OM [14]. Thus, it is expected that NTHI
molecules contained in middle ear effusion may gain more
chances to enter the inner ear, but it is poorly understood
how NTHI-induced OM leads to inner ear inflammation.
Recently, we have demonstrated that spiral ligament
fibrocytes (SLFs) release chemokines in response to OM
pathogens [15]. Among the inner ear cells, we proposed
SLFs as a main responder to the inflammatory stimuli
because SLFs, one of the most abundant inner ear cell
types, express pathogen recognition receptors such as
toll-like receptor 2 (TLR2) [16]. We believe that SLFs
recognize OM pathogens entering the inner ear and
release chemokines recruiting inflammatory cells such
as monocytes. Monocytes are known to infiltrate the
cochlea in chronic middle ear inflammation [17] as well
as after acoustic trauma [18]. Previously, we demon-
strated that SLFs up-regulate monocyte chemoattractant
protein-1 (MCP-1/CCL2) in response to NTHI through
TLR2-dependent NF-kB activation [16]. Therefore, we
hypothesize that OM pathogen-induced SLF-derived
MCP-1/CCL2 plays a major role in inner ear inflamma-
tion secondary to OM. We here show that NTHI-
induced SLF-derived MCP-1/CCL2 contributes to
OM-induced inner ear inflammation through the CCR2-
mediated recruitment of monocytes. However, we found
that inhibition of MCP-1/CCL2 or CCR2 alone is lim-
ited to inhibit OM-induced inner ear inflammation
since targeting the MCP-1/CCL2 gene affects expression
of alternative genes such as MCP-2/CCL8.
Methods
Reagents
Recombinant MCP-1/CCL2 and RS102895 (a chemical
inhibitor of CCR2) was purchased from Sigma (St. Louis,
MO). Recombinant viral CC chemokine inhibitor (CCI)
was purchased from R&D Systems (Minneapolis, MN).
Bacterial culture and preparation of bacterial lysate
NTHI strain 12 that was used is originally a clinical iso-
late from the middle ear fluid of a child with acute
OM [19]. To restore virulence, 250 μl of NTHI suspen-
sion (10
5 cfu/ml) was inoculated into the murine perito-
neal cavity and recovered with peritoneal lavage the
next day. The NTHI lysate was prepared as described
previously [20]. Briefly, a single colony of NTHI was
harvested from a chocolate agar plate, inoculated into
30 ml of brain heart infusion broth supplemented with
NAD (3.5 μg/ml) and incubated overnight. The superna-
tant was discarded after centrifugation at 10,000 × g for
10 min. The pellet was resuspended in 10 ml of phos-
phate-buffered saline (PBS) and sonicated to lyse the
bacteria. The lysate was then centrifuged at 10,000 × g
for 10 min, and the supernatant was collected.
Cell culture
In this study, we used the rat SLF cell line, immortalized
with adenovirus type 12-simian virus 40 hybrid virus
[21], primary murine SLFs, THP-1 cells (ATCC,
Manassas, VA) and primary murine splenocytes. The rat
SLF cell line was maintained in DMEM (Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine
serum, penicillin (100 units/ml), and streptomycin (0.1
mg/ml). Primary SLFs were cultured from explants of
the mouse cochlear lateral walls as previously described
[16]. THP-1 cells were maintained in suspension in
RPMI 1640 containing 10% fetal bovine serum, penicil-
lin (100 U/ml), streptomycin (100 mg/ml) and 2-mer-
captoethanol (50 μM) at a density of 5 × 10
5 cells/ml.
For harvesting splenocytes, mouse spleen was aseptically
dissected after euthanization and was homogenized
b e t w e e nt h ef r o s t e de n d so ft h eg l a s ss l i d e si nt h e
DMEM. The homogenized spleen was passed through
the nylon mesh and cells were treated with ACK lysis
buffer to remove red blood cells.
Animals
C57BL/6, MCP-1
-/-, CCR2
-/- and TNF
-/- mice were pur-
chased from the Jackson Laboratory (Bar Harbor, ME).
All aspects of animal handling were performed accord-
ing to the approved IACUC guidelines (HE1131-09-03).
10
7 cfu of live NTHI was suspended in 10 μl of saline
and was transtympanically inoculated into the middle
ear of the young adult male mice using a 27 G needle
and syringe under the surgical microscope. As a control,
sterile normal saline was inoculated with the same pro-
cedure. Animals were sacrificed at 3, 5 and 7 days after
inoculation and temporal bones were dissected. After
fixation and decalcification, the temporal bone was
embedded in paraffin and was serially sectioned through
the mid-modiolar plane at a thickness of 10 μm. H & E
staining and immunolabeling was performed for the his-
tological analysis. According to the classification of
human temporal bones with a history of OM [22], we
divided these inner ear inflammatory responses into
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(showing accumulation of serous substances and hemor-
rhage with none or minimal infiltration of inflammatory
cells); and 3) purulent labyrinthitis (showing massive
infiltration of inflammatory cells). For immunolabeling,
endogenous peroxidase activity was quenched with 0.3%
H2O2, and nonspecific binding sites were blocked with
horse serum (1:500). Sections were incubated with poly-
clonal rabbit anti-MCP-1 antibody (1:200, Santa Cruz
Biotechnology, Santa Cruz, CA) and biotinylated anti-
rabbit IgG antibody (Vector Laboratories, Burlingame,
CA). Bound secondary antibodies were detected by the
reaction of diaminobenzidine tetrahydrochloride with
peroxidase that was attached by the avidin-biotin com-
plex method.
Migration and invasion assays
After overnight starvation, SLFs were exposed to the
NTHI lysate (0.1 μg/ml) for 12 h and the conditioned
medium was collected. As a control, the conditioned
medium of SLFs was separately collected without NTHI
exposure. Migration assays were performed using Cyto-
Select™24-well cell migration assay kit (Cell Biolabs, San
Diego, CA) with the polycarbonate membrane inserts
(5 μm pores) according to the manufacturer’si n s t r u c -
tions. Briefly, suspended THP-1 cells or primary spleno-
cytes were added to each insert (300 μl) at a density of
1×1 0
6 cell/insert and the conditioned medium was
added to the lower chamber. Cells were allowed to
migrate for 12 h, and migrated cells were lysed and
detected with CyQuant GR dye solution (Invitrogen,
Carlsbad, CA). Fluorescence was measured with a plate
reader at 480 nm/520 nm. For the invasion assays, poly-
carbonate membrane inserts (8 μmp o r e s )c o a t e dw i t h
basement membrane matrix were used.
Real-time quantitative PCR and silencing of MCP-1/CCL2
Real-time quantitative PCR was performed as described
previously [20]. Briefly, after SLFs were exposed to the
NTHI lysate, total RNA was extracted using the RNeasy
kit (Qiagen, Valencia, CA), and cDNA was synthesized
using the TaqMan reverse transcription kit (Applied
Biosystems). Real time quantitative PCR was performed
with Syber Green Master Mix and primers specific to
mouse MCP-1/CCL2 (NM_011333: 5’-TCACCTGCT
GCTACTCATTCACCA-3’;5 ’-TACAGCTTCTTTGG
GACACCTGCT-3’), MCP-2/CCL8 (NM_021443: 5’-
AGCCTTGAACCTTCACACCTGAGT-3’;5 ’-CCAG
GCACCATCTGCTTGTAACAT-3’), MCP-3/CCL7
(NM_013654: 5’-ACCAACCTAGGAGCCAAGAAG
CAA-3’;5 ’-AAGACCATTCCTTAGGCGTGACCA-3’),
CCR1 (NM_009912: 5’-ACCAGTTCCTCAGCAAAG
GATGGA-3’;5 ’-TAGGACATTGCCCACCACTCCAAT-
3’) and CCR2 (NM_009915: 5’-TCCTCAGTACCTTTG-
CAACTGCCT-3’;5 ’-AGCAAGACTTCTGTCCCTGCT-
TCA-3’). The cycle threshold (CT) values were deter-
mined according to the manufacturer’s instructions, and
the relative quantity of mRNA was determined using
the 2
-(ΔΔCT) method [23]. CT values were normalized to
the internal control (GAPDH), and the results were
expressed as a fold change of mRNA, taking mRNA
levels of the non-treated group as 1. For the silencing of
MCP-1/CCL2 expression, cells were transfected
with MCP-1-specific siRNA (s128379, Ambion, Austin,
TX) using the siPORT™ NeoFX™ transfection agent
(Ambion), according to the manufacturer’si n s t r u c t i o n .
As a control, the negative control siRNA (Ambion) was
transfected in parallel.
Statistics
All experiments were carried out in triplicate and
repeated two or three times. Results were expressed as
means + standard deviations. Statistical analysis was per-
formed using Student’s t test and Fisher’s exact test with
significance considered to be a p value of < 0.05.
Results and Discussion
1. Inoculation of NTHI into the middle ear leads to
labyrinthitis
It is known that middle ear inflammation leads to inner
ear inflammation resulting in inner ear dysfunction [24].
To establish a murine model for OM-induced inner ear
inflammation, live NTHI was inoculated into the murine
middle ear through the tympanic membrane after
restoration of virulence by animal peritoneal passing.
T h ep i l o ts t u d yd e t e r m i n e d1 0
7 cfu as the optimal
bacterial dosage of NTHI for the development of OM-
induced inner ear inflammation in C57BL/6 mice. Mur-
ine temporal bones were harvested at 7 days after
bacterial inoculation and histological analysis was per-
formed. An incubation period shorter than 7 days was
insufficient for the development of OM-induced inner
ear inflammation. Histological analysis showed that mid-
dle ear infection leads to inner ear inflammatory
responses such as accumulation of serous substances,
hemorrhage and infiltration of inflammatory cells (Fig-
ure 1). As shown in Table 1, transtympanic inoculation
of live NTHI significantly caused inner ear inflammation
in 93% of ears including serous (21%) and purulent
(71%) labyrinthitis, compared to 50% in the control ani-
mals (p <0 . 0 5 ) .I tw a sn o t e dt h a tl a b y r i n t h i t i sr e m a i n s
after clearance of middle ear inflammation, indicating
inner ear inflammation occurs as a complication of OM.
The incidence of SNHL attributed to OM is known to
be less than 5% although it may be underestimated due
to difficulties in testing [14,25-27]. In our mouse model,
NTHI-induced OM caused labyrinthitis more frequently
than expected, which may occur due to a thinner round
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round window membrane is the major route from the
middle ear to the inner ear, since it is the only non-
bony barrier between two structures. Its permeability is
known to be affected by exposure to inflammatory con-
ditions [29-31]. Inflammatory mediators or bacterial
molecules such as endotoxin or exotoxin compromise
the round window membrane permeability barrier and
diffuse into the perilymph [9,32,33]. Once in the inner
ear, these molecules induce pathologic changes includ-
ing inflammation of the perilymphatic space and the
spiral ligament, strial swelling, sensory cell degeneration
[33] and fibrinogen deposition [11].
2. NTHI-induced SLF-derived molecules attract THP-1 cells
After entering the cochlea from the middle ear through
the round window membrane, bacterial molecules in the
perilymph of the scala tympani are expected to make
contact with the cochlear structures such as the spiral
ligament laterally and the osseous spiral lamina medially.
The spiral ligament is a connective tissue structure
made up of SLFs and collagen fibrils that forms the lat-
eral wall of the cochlea. In particular, the spiral liga-
ment-facing scala tympani is not completely covered
with lining epithelial cells, thus allowing free flow of
perilymph to SLFs [34]. To determine if SLFs release
molecules attracting monocytes in response to NTHI,
we performed migration assays using THP-1 cells (the
human acute monocytic leukemia cell line) and the con-
ditioned medium of NTHI-exposed SLFs. Migration
assays showed that THP-1 cells migrated in response to
the conditioned medium of NTHI-exposed SLFs more
actively than the conditioned medium without NTHI
exposure, indicating that SLFs release molecules attract-
ing THP-1 cells in response to NTHI (Figure 2A).
Next, we performed invasion assays to determine if
Figure 1 Inner ear inflammation secondary to NTHI-induced middle ear infection. Live NTHI was inoculated into the murine middle ear
through the tympanic membrane and temporal bones were harvested at 7 days after bacterial inoculation. H & E staining shows that middle
ear infection results in serous labyrinthitis (A) and purulent labyrinthitis (B). Note accumulation of serous substances with hemorrhage (arrow)
and massive infiltration of inflammatory cells (arrowhead) in the cochlear spaces. Original magnification: ×50.
Table 1 NTHI-induced inner ear inflammation in wild type, MCP-1-deficient and CCR2-deficient mice
Mice Inoculation
(mice)
No inflammation
(ears)
Serous labyrinthitis
(ears)
Purulent labyrinthitis
(ears)
Fisher’s exact test
Wild type Saline
a
(4)
42 2
NTHI
b
(7)
1 3 10 a vs. b:p< 0.05
MCP-1
-/- NTHI
c
(5)
0 4 6 b vs. c: NS
CCR2
-/- NTHI
d
(5)
0 0 10 b vs. d: NS
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of THP-1 cells. We found that THP-1 cells invaded the
extracellular matrix in response to the conditioned med-
ium of NTHI-exposed SLFs (Figure 2B &2C). However,
the NTHI molecules per se did not affect migration and
invasion of THP-1 cells, compared to NTHI-induced
SLF-derived molecules.
We believe that monocytes play a critical role in OM-
induced inner ear inflammation, similar to acoustic
trauma, which also induces infiltration of monocytes
[18,35,36]. Monocytes are a major element of the innate
immunity defense to pathogen invasion, but their
overly-robust response can lead to pathological sequelae
resulting in tissue damage. Monocytes recruited to the
cochlea are thought to be involved in both propagation
of tissue damage, resulting in sensorineural hearing loss,
and local disposal of injured cochlear cells as a wound-
healing process.
3. MCP-1/CCL2 is a main attractant for THP-1 cells among
the NTHI-induced SLF-derived molecules
Monocytes are known to be attracted by a number of
molecules such as complement C5a and monocyte che-
motactic proteins (MCPs) [37,38]. To determine a criti-
cal molecule involved in attraction of THP-1 cells
among the NTHI-induced SLF-derived molecules, we
conducted migration assays with a viral CC chemokine
inhibitor (vCCI). As shown in Figure 3A, recombinant
vCCI suppressed migration of THP-1 cells attracted by
the NTHI-induced SLF-derived molecules in a dose-
dependent manner, indicating the involvement of CC
chemokines. Among CC chemokines, we explored silen-
cing MCP-1/CCL2 expression, based on our previous
data showing that SLFs released high levels of MCP-1/
CCL2 upon exposure to the OM pathogens [15]. SLFs
were transfected with either non-specific siRNA (NC) or
rat MCP-1-specific siRNA. Cells were exposed to the
NTHI lysate and the conditioned culture medium was
harvested. Migration assays demonstrated that THP-1
cells poorly migrated in response to the conditioned
medium of MCP-1-silenced SLFs, and this inhibition
was restored by the addition of recombinant MCP-1/
CCL2 in a dose-dependent manner (Figure 3B). qRT-
PCR showed that the MCP-1-specific siRNA inhibits
MCP-1/CCL2 expression more than 60% compared to
the NC siRNA (data not shown). Next, we sought to
determine if MCP-1/CCL2 deficiency affects chemotac-
tic activity of NTHI-induced SLF-derived molecules.
We isolated and cultured primary SLFs from the wild-
type mice, the MCP-1-deficient mice and the TNF-a-
deficient mice as described previously [16]. Migration
assays showed that MCP-1 deficiency, not TNF-a defi-
ciency, significantly inhibits THP-1 cell migration
attracted by NTHI-induced SLF-derived molecules
Figure 2 Attraction of THP-1 cells by SLFs-derived molecules. The culture medium of SLFs was collected after 6, 12 and 24 h with or
without exposure to the NTHI lysate, respectively. Migration assays show that the conditioned medium of NTHI-exposed SLFs highly attracts
THP-1 cells compared to that of NTHI-unexposed SLFs (A). RFU: relative fluorescence unit. Invasion assays show that NTHI-induced SLF-derived
molecules enhance invasion of THP-1 cells (dark and solid) to the extracellular matrix on the semi-permeable membrane with pores (light and
open) (B). It is noted that NTHI lysate per se does not affect migration and invasion of THP-1 cells, compared to the NTHI-induced SLF-derived
molecules (C). *: p < 0.05. The experiments were performed in triplicate and repeated twice. Values are given as the mean ± standard deviation
(n = 3).
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indicate that MCP-1/CCL2 is a main attractant for
THP-1 cells among the NTHI-induced SLF-derived
molecules in vitro. To determine if MCP-1/CCL2 is
associated with inner ear inflammation secondary to
NTHI-induced OM in vivo, immunolabeling of NTHI-
inoculated temporal bone sections was performed
using a polyclonal anti-MCP-1 antibody. As shown in
Figure 4, spiral ligaments highly expressed MCP-1 in
NTHI-inoculated mice, compared to saline-inoculated
mice. Particularly, the serous substances in the
cochlear spaces were labeled strongly with an anti-
MCP-1 antibody, suggesting that they may contain the
released MCP-1/CCL2.
MCP-1/CCL2, one of the most studied chemokines,
is produced by a variety of cells such as fibroblasts and
macrophages, either constitutively or after induction by
inflammatory stimuli [39-41]. MCP-1/CCL2 is known
to be involved in a number of immune diseases includ-
ing atherosclerosis and insulin-resistant diabetes
[42,43]. In this study, we showed that SLF-derived
MCP-1/CCL2 contributes to OM-induced inner ear
inflammation through recruiting monocytes. In addi-
tion to inflammatory infiltration, monocytes constitu-
tively migrate from blood to tissue for maintaining
resident macrophages. Cochlear resident macrophages
are found to be localized in the spiral ligament and the
spiral ganglion area [44], but further studies are neces-
sary to elucidate a mechanism related to the homing
of monocytes to the cochlea.
4. CCR2 is required for the migration of THP-1 cells in
response to the NTHI-induced SLF-derived molecules
According to the classification based on the spacing of
the N-terminal cysteine residues, CCR2 belongs to the
b- s u b c l a s so fc h e m o k i n er e c e p t o r s ,w h i c hs e r v e sa sa
receptor for the natural ligands such as MCP-1/CCL2
and MCP-2/CCL8 [45]. To determine an involvement of
CCR2 in monocyte recruitment induced by SLF-derived
molecules, migration assays were performed after block-
ing of CCR2 with a CCR2 inhibitor (RS 102895). Migra-
tion assays showed that RS 102895 markedly inhibits
migration of THP-1 cells in response to NTHI-induced
SLF-derived molecules in a dose-dependent manner
(Figure 5A). There are two isoforms of CCR2 as a result
of alternative splicing [46]. CCR2a is the major isoform
expressed by vascular smooth muscle cells while mono-
cytes and activated NK cells express predominantly the
CCR2b [47]. Compared to CCR2a, CCR2b is more sen-
sitive to MCP-1/CCL2, which is selectively inhibited by
RS 102895.
To determine if CCR2 deficiency affects chemotactic
activity of NTHI-induced SLF-derived molecules, we
performed migration assays using primary splenocytes
of mice. Migrated cells were collected and Giemsa stain-
ing was performed after cytospin preparation. It was
found that NTHI-exposed conditioned medium of SLFs
attracts large cells with abundant cytoplasm resembling
activated monocytes in the wild type mice (Figure 5B).
In contrast, monocyte-like cells of CCR2-deficient sple-
nocytes poorly migrated in response to NTHI-induced
Figure 3 Identification of the main molecule attracting THP-1 cells among NTHI-induced molecules derived from SLFs.V i r a lC C
chemokine inhibitor (CCI) blocks migration of THP-1 cells responding to the NTHI-induced SLF-derived molecules (A). Migration assays were
performed using THP-1 cells and the conditioned medium of NTHI-exposed SLFs with and without treatment of CCI (0.02, 0.1 and 0.5 μg/ml) for
12 h and 36 h. Silencing of MCP-1/CCL2 inhibits migration of THP-1 cells attracted by the conditioned medium of NTHI-exposed SLFs, which is
restored by addition of the recombinant MCP-1/CCL2 (rMCP-1, 0.1 and 1 ng/ml) (B). SLFs were transfected with either non-specific siRNA (NC) or
MCP-1-specific siRNA (MCP-1) and culture medium was collected after 12 h with and without exposure to the NTHI lysate. Results were
expressed relative to the fold change of mRNA levels, taking the value of the NC siRNA-treated group as 1. THP-1 cell migration in response to
the conditioned medium of NTHI-exposed SLFs is inhibited more than 60% by MCP-1/CCL2 deficiency, but not by TNF-a deficiency (C). Primary
SLFs were cultured in the lower compartment of the migration chamber and were exposed to the NTHI lysate. THP-1 cells were co-cultured in
the upper compartment, and migrated cells to the lower chamber were quantitated using a hemocytometer. The experiments were performed
in triplicate and repeated twice. Values are given as the mean ± standard deviation (n = 3). *: p < 0.05.
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CCR2 for the migration of monocyte-like cells in
response to NTHI-induced SLF-derived molecules.
MCP-1/CCL2 interacts only with CCR2, whereas CCR2
responds to both agonists (e.g., MCP-2/CCL8) and
antagonists (e.g., CCL11) [48]. Therefore, it is challen-
ging to understand the in vivo implications of interac-
tions between chemokines and corresponding receptors.
5. Deficiency of MCP-1/CCL2 or CCR2 alone is limited for
the inhibition of OM-induced inner ear inflammation
To determine if the deficiency of MCP-1/CCL2 or CCR2
affects OM-induced inner ear inflammation in vivo,l i v e
NTHI was transtympanically inoculated into the middle
ear of the wild type, MCP-1/CCL2-deficient and CCR2-
deficient mice. Contrary to our in vitro data, neither
MCP-1/CCL2 deficiency nor CCR2 deficiency signifi-
cantly inhibited OM-induced inner ear inflammation
(Table 1). Previously, we have shown that lysozyme P
expression is up-regulated in lysozyme M-deficient mice
[49], which suggests that the targeting of one gene affects
the regulation of its alternative genes for compensation
[50]. Moreover, since it has been reported that targeting
of the MCP-1/CCL2 gene affects lipopolysaccharide-
induced MCP-3/CCL7 production [51], we hypothesized
that MCP-1/CCL2 deficiency by the insertion of a neo-
gene cassette is compensated by the up-regulation of
other MCPs. We compared NTHI-induced transcrip-
tional regulation of MCP-2/CCL8 and MCP-3/CCL7 in
the wild type mouse and the MCP-1/CCL2-deficient
Figure 4 SLF-derived MCP-1/CCL2 is associated with inner ear inflammation secondary to NTHI-induced OM in vivo. Murine temporal
bones were harvested at 7 days after transtympanic inoculation of saline (A) and live NTHI (B). Immunolabeling shows MCP-1/CCL2 is highly
expressed in the spiral ligaments (white arrows) and spiral limbus as well as the serous substances (black arrow) of the NTHI-inoculated mice. In
contrast, it is noted that the cochlea of the saline-inoculated group weakly expresses MCP-1/CCL2 except the stria vascularis (arrowheads).
Original magnification: ×50.
Figure 5 Requirement of CCR2 for migration of monocytes in response to NTHI-induced SLF-derived molecules. Migration assays show
that the CCR2 inhibitor (RS 102895) markedly inhibits migration of THP-1 cells attracted by NTHI-induced SLF-derived molecules, in a dose-
dependent manner (A). Giemsa staining of the migrated splenocytes shows that CCR2 deficiency inhibits migration of monocyte-like cells in
response to the NTHI-induced SLF-derived molecules (B).
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lation of MCP-2/CCL8 was highly enhanced by the tar-
geting of the MCP-1/CCL2 gene in SLFs, whereas the
regulation of MCP-3/CCL7 was not affected. Considering
that MCP-1/CCL2 interacts only with CCR2 but MCP-2/
CCL8 activates CCR1 and CCR3 in addition to CCR2, we
suggest that SLF-derived MCP-2/CCL8 may induce inner
ear inflammation instead of MCP-1/CCL2.
It has been reported that CCR2 deficiency did not
suppress noise-induced monocyte migration into the
cochlea and dramatically increased noise-induced hair
cell death [52], suggesting either an over-compensation
of CCR2 deficiency or the presence of a CCR2-mediated
protective mechanism. Thus, we investigated the effect
of CCR2 deficiency on the regulation of CCR2 ligands
and other chemokine receptors. As shown in Figure 6B,
CCR2 deficiency enhanced NTHI-induced up-regulation
of MCP-1/CCL2 in SLFs in accordance with previous
reports [53,54]. In contrast, MCP-2/CCL8 expression
did not appear to be affected by CCR2 deficiency. We
also found that MCP-1/CCL2 deficiency highly up-regu-
lates the basal expression of CCR2 but CCR1 expression
is not affected, taking the CCR2 level of the wild type
splenocytes as 1 (Figure 6C). Altogether, we suggest that
the deficiency of MCP-1/CCL2 or CCR2 is compensated
by up-regulation of alternative genes in the inner ear in
vivo, resulting in the discrepancy between in vitro and
in vivo data.
In agreement with our findings, acoustic trauma-
induced cochlear inflammation is known to be
unaffected by single MCP-1/CCL2- or CCR2-deficiency
[52]. Moreover, it has been reported that macrophage
migration through the blood-brain barrier is not influ-
enced by single MCP-1/CCL2- or CCR2-deficiency, but
double-deficient mice lead to a virtual absence of blood-
borne macrophage recruitment [55]. Cochlea and brain
have in common a blood-tissue barrier [56]. In other
s y s t e m sw i t h o u tab l o o d - t i s s u eb a r r i e r ,s i n g l eM C P - 1 /
CCL2 deficiency is found to effectively inhibit MCP-1/
CCL2-mediated diseases such as atherosclerosis [57] and
diabetes [58]. Therefore, we suggest that this barrier
m a yb ei n v o l v e di nc o m p e n s a t i o no fs i n g l eM C P - 1 /
CCL2- or CCR2-deficiency, but further studies are
necessary.
It remains unclear how targeting an MCP-1/CCL2
gene regulates expression of other MCPs. Recently, it
has been reported that lipopolysaccharide-induced
MCP-3/CCL7 production is down-regulated by the tar-
geting of an MCP-1/CCL2 gene with the insertion of a
neo-gene cassette, but is up-regulated by the deletion of
the MCP-1/CCL2 gene [51]. Since the MCP-1/CCL2
gene is located upstream from other MCPs genes, the
disruption of the MCP-1/CCL2 gene may alter the DNA
conformation at the locus, resulting in aberrant tran-
scription of genes such as MCP-2/CCL8 and MCP-3/
CCL7 that are downstream from the MCP-1/CCL2
gene. In addition to MCP-2/CCL8, we believe that other
genes, which are not tested in the study, may be affected
by the targeting of MCP-1/CCL2 and contribute to the
discrepancy of our in vitro and in vivo findings.
Figure 6 Deficiency of MCP-1/CCL2 and CCR2 affects NTHI-induced regulation of other CC chemokines. qRT-PCR shows that NTHI-
induced up-regulation of MCP-2/CCL8 is markedly enhanced in SLFs of MCP-1
-/- mice compared to the wild type mouse (A). It is noted that the
regulation of MCP-3/CCL7 is not affected. CCR2 deficiency enhances NTHI-induced up-regulation of MCP-1/CCL2, but not MCP-2/CCL8 (B).
Primary SLFs derived from the wild type, MCP-1-deficient and CCR2-deficient mice were exposed to the NTHI lysate for 3 h. Results were
expressed relative to the fold change of mRNA levels, taking the value of the non-treated group as 1. MCP-1/CCL2 deficiency up-regulates CCR2
expression in the splenocytes, but CCR1 expression is not affected (C). mRNA levels of CCR1 and CCR2 were relatively shown, taking the CCR2
level of the wild type splenocytes as 1. *: p < 0.05. The experiments were performed in triplicate and repeated three times. Values are given as
the mean ± standard deviation.
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In this study, we showed that SLFs, in response to
NTHI, release molecules attracting monocytes. Among
NTHI-induced SLF-derived molecules, we demonstrated
that MCP-1/CCL2 is a major attractant enhancing
migration and invasion of monocytes. We also found
that CCR2 is required for monocyte recruitment
responding to NTHI-induced SLF-derived molecules.
However, deficiency of MCP-1/CCL2 or CCR2 alone
produced limited inhibition of OM-induced inner ear
inflammation since targeting a gene affected expression
of alternative genes. In summary, we suggest that
NTHI-induced SLF-derived MCP-1/CCL2 contributes to
OM-induced inner ear inflammation through CCR2-
mediated recruitment of monocytes. We believe that
our findings will enable us to further understand the
molecular pathogenesis of OM-induced inner ear
inflammation.
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